Otsuka America Pharmaceutical, Inc., a subsidiary of Otsuka Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in the United States. Founded in 1973, the company has established a strong presence in key operational regions, focusing on innovative treatments in areas such as mental health, nephrology, and oncology. Otsuka is renowned for its unique products, including the groundbreaking antipsychotic medication Abilify and the first oral treatment for polycystic kidney disease, Jynarque. These offerings highlight the company's commitment to addressing unmet medical needs through research and development. With a reputation for innovation and a robust pipeline, Otsuka America continues to solidify its market position, contributing significantly to advancements in healthcare.
We don't have data for Otsuka America Pharmaceutical, Inc, but we can show you information about their parent organization instead.
View parent company